Trademark: 97435951
Status Date
Monday, March 11, 2024
Filing Date
Tuesday, May 31, 2022
Published for Opposition
Tuesday, July 18, 2023
5 Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific reagent antibodies for medical diagnosis purposes
16 Printed educational and informational publications related to cancer, namely, pamphlets, newsletters, guides
1 Multitarget, multiepitope, multivalent centralized antibody molecule structure used to incorporate multiple target antigen binders into a single antibody, namely, multi-specific therapeutic antibodies for scientific and medical research
44 Providing healthcare information regarding cancer drugs and cancer treatment
42 Providing prescription drug research information relating to cancer drugs
Mar 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2024
Sou Extension 1 Granted
Mar 11, 2024
Sou Extension 1 Filed
Mar 11, 2024
Sou Teas Extension Received
Sep 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 18, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 18, 2023
Published For Opposition
Jun 28, 2023
Notification Of Notice Of Publication E-Mailed
Jun 14, 2023
Approved For Pub - Principal Register
Jun 13, 2023
Teas/Email Correspondence Entered
Jun 13, 2023
Correspondence Received In Law Office
Jun 13, 2023
Teas Response To Office Action Received
Mar 17, 2023
Notification Of Non-Final Action E-Mailed
Mar 17, 2023
Non-Final Action E-Mailed
Mar 17, 2023
Non-Final Action Written
Mar 16, 2023
Assigned To Examiner
Jun 7, 2022
New Application Office Supplied Data Entered
Jun 3, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
